23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
4.700
+0.050 (1.08%)
At close: Nov 4, 2024, 4:00 PM
4.643
-0.057 (-1.21%)
After-hours: Nov 4, 2024, 5:54 PM EST
23andMe Holding Co. Employees
As of March 31, 2024, 23andMe Holding Co. had 582 total employees, including 560 full-time and 22 part-time employees. The number of employees decreased by 234 or -28.68% compared to the previous year.
Employees
582
Change (1Y)
-234
Growth (1Y)
-28.68%
Revenue / Employee
$342,247
Profits / Employee
-$1,085,017
Market Cap
121.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 582 | -234 | -28.68% |
| Mar 31, 2023 | 816 | 48 | 6.25% |
| Mar 31, 2022 | 768 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 908 Devices | 230 |
| Pro-Dex | 148 |
| TriSalus Life Sciences | 112 |
| KORU Medical Systems | 82 |
| Fennec Pharmaceuticals | 29 |
| PDS Biotechnology | 25 |
| Avalo Therapeutics | 19 |
| Annovis Bio | 16 |
ME News
- 5 days ago - 23andMe Regains Compliance With Nasdaq Listing Requirements - GlobeNewsWire
- 5 days ago - 23andMe appoints new board members as it works to stem the company's slide - Business Insider
- 6 days ago - 23andMe appoints three new board members following abrupt resignations - CNBC
- 6 days ago - 23andMe Appoints Three New Independent Directors to Board - GlobeNewsWire
- 7 days ago - DNA & RNA Banking Services Market Report 2024-2030, Featuring EasyDNA, DNA Genotek, 23andMe, GoodCell, ProteoGenex, Infinity Biologix, deCODE genetics, LGC Biosearch Technologies & PreventionGenetics - GlobeNewsWire
- 12 days ago - Inside the fall of 23andMe - CNBC
- 19 days ago - 23andMe Announces Completion of 1-for-20 Reverse Stock Split - GlobeNewsWire
- 24 days ago - 23andMe Announces 1-for-20 Reverse Stock Split - GlobeNewsWire